Sep 04, 2024 / 06:30AM GMT
Sibongakonke Nkosi - Aspen Pharmacare Holdings Ltd - Investor Relations
Good morning, everyone. It's good to see you all here today and welcome to Aspen's full year financial results for the 2024 period. In today's program, we're going to have Steven, he's going to start us off with the performance overview. Sean will then follow with the financial highlights and review. Steven will then return and he's going to give us the strategic review and some outlook, and then we'll move on to questions-and-answers. (Operator Instructions)
Thank you all. Over to you, Steven.
Stephen Saad - Aspen Pharmacare Holdings Ltd - Group Chief Executive, Executive Director
Thank you for your attendance and for, I believe there are many more online, so welcome to all that are listening. I think, if we reflect on where we are and where we're going to, the second half was a really important half for Aspen. We flagged it over a year ago as being a critical inflection point for Aspen. And indeed, it was. We had some very important deliverables. Now after the last seven to eight
Full Year 2024 Aspen Pharmacare Holdings Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot